查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1590641

女性不孕和妊娠快速检测市场：按设备类型、检测类型、类型、分销管道划分 - 2025-2030 年全球预测

Female Fertility & Pregnancy Rapid Test Market by Device Type (Digital Devices, Line-Indicator Devices), Test Type (FSH Urine Test, HCG Blood Test, HCG Urine Test), Type, Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

女性不孕及妊娠快速检测市场2023年估值为19.5亿美元，预计2024年将达21亿美元，复合年增长率为7.72%，预计到2030年将达32.9亿美元。

快速女性不孕症和妊娠检测市场包括各种旨在检测与不孕症和怀孕相关的特定荷尔蒙的诊断产品。这些测试对于为妇女提供及时、准确的生殖状况资讯至关重要，从而有助于计划生育和医疗保健决策。这些测试广泛应用于临床、家庭和零售环境，提供便利和隐私。人们对妇女健康和生殖计划的认识不断提高，以及对商业诊断解决方案的需求不断增长，推动了市场需求。最终用途范围包括医院、诊断中心和居家照护环境，反映了这些工具的多功能性和广泛的应用范围。

主要市场统计
基准年[2023] 19.5亿美元
预测年份 [2024] 21亿美元
预测年份 [2030] 32.9亿美元
复合年增长率（%） 7.72%

影响成长的关键因素包括诊断技术的进步、医疗保健支出的增加以及由于生活方式改变和延迟妊娠等因素导致的不孕症和妊娠相关併发症的发生率增加。市场扩张的机会在于拥有已开发医疗基础设施和数位测试和智慧型手机整合测试等产品创新的新兴国家。透过专注于易用性和可负担性，公司可以利用这些机会，提高消费者满意度并扩大市场范围。

然而，他们面临着限制市场渗透的挑战，包括严格的监管要求、不准确的测试结果以及某些地区的文化障碍。在创新方面，在开发更敏感和特异性的测试、探索使用人工智慧来增强预测分析以及整合资料管理系统来追踪结果方面存在重大机会。

快速发展的女性不孕和妊娠检测市场充满活力，越来越多地转向个人化医疗保健解决方案。为了实现最佳业务成长，公司应专注于与医疗保健提供者和科技公司合作，利用数位健康趋势，同时有效适应监管环境，快速、合规地推出新产品。

市场动态：针对快速发展的女性不孕症和怀孕快速检测市场揭示的关键市场洞察

供需的动态交互作用正在改变快速的女性不孕症和妊娠检测市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 与耗时的实验室测试相比，对快速、自足式测试的需求不断增加
    • 不孕症和妇科疾病盛行率增加
  • 市场限制因素
    • 由于选择太多而导致选择的荒唐
    • 争议和设备相关问题
  • 市场机会
    • 技术进步和有吸引力的产品功能，例如与智慧型手机应用程式的集成
    • 提高新兴经济体套件的认识
  • 市场挑战
    • 提供错误率较低的替代诊断测试，例如血液测试和基于试剂的实验室测试

波特五力：引领女性不孕症与怀孕快速侦测市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解外部对女性不孕症/怀孕快速检测市场的影响

外部宏观环境因素在塑造女性不孕症和妊娠快速检测市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解女性不孕/妊娠快速检测市场的竞争状况

对快速女性不孕和妊娠测试市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的见解，以应对日益激烈的竞争。

FPNV 定位矩阵女性不孕不孕快速检测市场供应商的绩效评估

FPNV定位矩阵是评估女性不孕症和怀孕快速检测市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议，为快速女性不孕和妊娠检测市场的成功指明道路

对于旨在加强其在全球市场的影响力的公司来说，对快速发展的女性不孕症和妊娠检测市场进行策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 与耗时的实验室测试相比，对快速、自足式测试的需求不断增长。
      • 不孕症和妇科疾病增加
    • 抑制因素
      • 选择过多导致选择不合理
      • 争议和设备相关问题
    • 机会
      • 技术进步和有吸引力的产品功能，例如与智慧型手机应用程式的集成
      • 提高新兴经济体对套件的认识
    • 任务
      • 提供错误率较低的替代诊断测试，例如血液测试和基于试剂的实验室测试
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章按设备类型分類的女性不孕和妊娠快速检测市场

  • 数位装置
  • 线路指示器装置

第七章按测试类型分類的女性不孕和妊娠快速检测市场

  • FSH尿液检查
  • 血液HCG检查
  • 尿液检查
  • LH尿液检查

第八章女性不孕/妊娠快速检测市场：按类型

  • 生育治疗快速检测套组
  • 快速妊娠检测套组

第九章 女性不孕/妊娠快速检测市场：依分销管道划分

  • 药局
  • 妇科/不孕症治疗诊所
  • 大卖场和超级市场
  • 在线的
  • 药局

第十章美洲快速女性不孕不育与妊娠检测市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太女性不孕不孕快速检测市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章 欧洲、中东和非洲快速发展的女性不孕症和妊娠检测市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Atlas Medical GmbH
  • bioMerieux SA
  • Church & Dwight Co., Inc.
  • EGENS GROUP
  • Eurofins Scientific
  • Everly Health, Inc.
  • Expedient Healthcare Marketing Private Limited
  • Genea Limited
  • Geratherm Medical AG
  • Novartis AG
  • OneCare Media
  • Prestige Consumer Healthcare Inc.
  • Progyny, Inc.
  • Quidel Corporation
  • Thermo Fisher Scientific
Product Code: MRR-43676CF4220F

The Female Fertility & Pregnancy Rapid Test Market was valued at USD 1.95 billion in 2023, expected to reach USD 2.10 billion in 2024, and is projected to grow at a CAGR of 7.72%, to USD 3.29 billion by 2030.

The female fertility and pregnancy rapid test market involves a broad spectrum of diagnostic products designed to detect specific hormones associated with fertility and pregnancy. These tests are essential for providing women with timely and accurate information about their reproductive status, thereby supporting family planning and healthcare decision-making. They are widely used in clinical, home, and retail settings, offering convenience and privacy. The market's necessity stems from the increasing awareness of health and reproductive planning among women, as well as the rising demand for over-the-counter diagnostic solutions. End-use scopes include hospitals, diagnostic centers, and home-care environments, reflecting the versatility and widespread application of these tools.

KEY MARKET STATISTICS
Base Year [2023] USD 1.95 billion
Estimated Year [2024] USD 2.10 billion
Forecast Year [2030] USD 3.29 billion
CAGR (%) 7.72%

Key influencing growth factors include advancements in diagnostic technology, increased healthcare expenditure, and a higher incidence of infertility and pregnancy-related complications, driven by factors such as lifestyle changes and delayed pregnancies. Opportunities for market expansion lie in emerging economies with improving healthcare infrastructures, as well as through product innovations like digital and smartphone-integrated tests. Companies can capitalize on these opportunities by focusing on user-friendliness and affordability, which can enhance consumer satisfaction and expand market reach.

However, the market faces challenges like strict regulatory requirements, occasional inaccuracies in test results, and cultural barriers in certain regions which may limit market penetration. In terms of innovation, there are significant opportunities in developing more sensitive and specific tests, exploring the use of AI for enhanced predictive analytics, and integrating data management systems for result tracking.

The female fertility and pregnancy rapid test market is dynamic, with a favorable shift towards personalized healthcare solutions. For optimal business growth, companies should focus on partnerships with healthcare providers and technology firms to leverage digital health trends, whilst navigating regulatory landscapes effectively to introduce new products swiftly and compliantly.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Female Fertility & Pregnancy Rapid Test Market

The Female Fertility & Pregnancy Rapid Test Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising demand for the quick and self-contained test than the time-consuming lab-based test
    • Growing incidence of infertility and gynecological disorders
  • Market Restraints
    • Absurdity of choice due to the availability of too many options
    • Controversies and device-related issues
  • Market Opportunities
    • Technological advancements and attractive product features such as smartphone app connectivity
    • Increasing awareness about the kits in the developing economies
  • Market Challenges
    • Availability of alternative diagnostic tests, such as blood test and reagent-based laboratory test with fewer chances of error

Porter's Five Forces: A Strategic Tool for Navigating the Female Fertility & Pregnancy Rapid Test Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Female Fertility & Pregnancy Rapid Test Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Female Fertility & Pregnancy Rapid Test Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Female Fertility & Pregnancy Rapid Test Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Female Fertility & Pregnancy Rapid Test Market

A detailed market share analysis in the Female Fertility & Pregnancy Rapid Test Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Female Fertility & Pregnancy Rapid Test Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Female Fertility & Pregnancy Rapid Test Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Female Fertility & Pregnancy Rapid Test Market

A strategic analysis of the Female Fertility & Pregnancy Rapid Test Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Female Fertility & Pregnancy Rapid Test Market, highlighting leading vendors and their innovative profiles. These include Atlas Medical GmbH, bioMerieux SA, Church & Dwight Co., Inc., EGENS GROUP, Eurofins Scientific, Everly Health, Inc., Expedient Healthcare Marketing Private Limited, Genea Limited, Geratherm Medical AG, Novartis AG, OneCare Media, Prestige Consumer Healthcare Inc., Progyny, Inc., Quidel Corporation, and Thermo Fisher Scientific.

Market Segmentation & Coverage

This research report categorizes the Female Fertility & Pregnancy Rapid Test Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Device Type, market is studied across Digital Devices and Line-Indicator Devices.
  • Based on Test Type, market is studied across FSH Urine Test, HCG Blood Test, HCG Urine Test, and LH Urine Test.
  • Based on Type, market is studied across Fertility Rapid Test Kits and Pregnancy Rapid Test Kits.
  • Based on Distribution Channel, market is studied across Drugstores, Gynecology & Fertility Clinics, Hypermarkets & Supermarkets, Online, and Pharmacies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising demand for the quick and self-contained test than the time-consuming lab-based test
      • 5.1.1.2. Growing incidence of infertility and gynecological disorders
    • 5.1.2. Restraints
      • 5.1.2.1. Absurdity of choice due to the availability of too many options
      • 5.1.2.2. Controversies and device-related issues
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements and attractive product features such as smartphone app connectivity
      • 5.1.3.2. Increasing awareness about the kits in the developing economies
    • 5.1.4. Challenges
      • 5.1.4.1. Availability of alternative diagnostic tests, such as blood test and reagent-based laboratory test with fewer chances of error
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Female Fertility & Pregnancy Rapid Test Market, by Device Type

  • 6.1. Introduction
  • 6.2. Digital Devices
  • 6.3. Line-Indicator Devices

7. Female Fertility & Pregnancy Rapid Test Market, by Test Type

  • 7.1. Introduction
  • 7.2. FSH Urine Test
  • 7.3. HCG Blood Test
  • 7.4. HCG Urine Test
  • 7.5. LH Urine Test

8. Female Fertility & Pregnancy Rapid Test Market, by Type

  • 8.1. Introduction
  • 8.2. Fertility Rapid Test Kits
  • 8.3. Pregnancy Rapid Test Kits

9. Female Fertility & Pregnancy Rapid Test Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Drugstores
  • 9.3. Gynecology & Fertility Clinics
  • 9.4. Hypermarkets & Supermarkets
  • 9.5. Online
  • 9.6. Pharmacies

10. Americas Female Fertility & Pregnancy Rapid Test Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Female Fertility & Pregnancy Rapid Test Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Female Fertility & Pregnancy Rapid Test Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Atlas Medical GmbH
  • 2. bioMerieux SA
  • 3. Church & Dwight Co., Inc.
  • 4. EGENS GROUP
  • 5. Eurofins Scientific
  • 6. Everly Health, Inc.
  • 7. Expedient Healthcare Marketing Private Limited
  • 8. Genea Limited
  • 9. Geratherm Medical AG
  • 10. Novartis AG
  • 11. OneCare Media
  • 12. Prestige Consumer Healthcare Inc.
  • 13. Progyny, Inc.
  • 14. Quidel Corporation
  • 15. Thermo Fisher Scientific

LIST OF FIGURES

  • FIGURE 1. FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET RESEARCH PROCESS
  • FIGURE 2. FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET DYNAMICS
  • TABLE 7. GLOBAL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DIGITAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY LINE-INDICATOR DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY FSH URINE TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY HCG BLOOD TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY HCG URINE TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY LH URINE TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY FERTILITY RAPID TEST KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY PREGNANCY RAPID TEST KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DRUGSTORES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY GYNECOLOGY & FERTILITY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY HYPERMARKETS & SUPERMARKETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 192. FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 193. FEMALE FERTILITY & PREGNANCY RAPID TEST MARKET, FPNV POSITIONING MATRIX, 2023